Terra Innovatum Global (NKLR)
NASDAQ:NKLR
Want to see NKLR full AI Analyst Report?
Top Page
Terra Innovatum Global
(NASDAQ:NKLR)
Select Model
Select Model
Rating:47Neutral
Price Target:
$5.00
▼(-17.49% Downside)
Action:Reiterated
Date:06/20/26
The score is held down primarily by weak financial fundamentals (pre-revenue, rising operating losses, cash burn, and negative equity) and bearish technical signals. The earnings call adds support via clear operational/regulatory progress and reported funding for FOAK, while valuation appears optically low but is less reliable given atypical earnings.
Positive Factors
Regulatory Progress
Formal NRC docketing moves the SOLO design into the agency's technical review, materially reducing regulatory uncertainty versus pre‑docket status. This creates a durable path toward construction and operating permits that underpins commercialization timing and customer confidence over the next 2–18 months.
Negative Factors
Pre‑revenue & Cash Burn
The company generates no product revenue and operating cash outflows have accelerated, implying continued reliance on financing. Persistent negative operating margins and free cash flow make long‑term viability contingent on successful FOAK, order conversion, or further capital raises.
Read all positive and negative factors
Positive Factors
Negative Factors
Regulatory Progress
Formal NRC docketing moves the SOLO design into the agency's technical review, materially reducing regulatory uncertainty versus pre‑docket status. This creates a durable path toward construction and operating permits that underpins commercialization timing and customer confidence over the next 2–18 months.
Read all positive factors
Terra Innovatum Global (NKLR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$567.97M
Dividend YieldN/A
Average Volume (3M)2.93M
Price to Earnings (P/E)0.5
Beta (1Y)-0.06
Revenue GrowthN/A
EPS Growth15261.66%
CountryUS
Employees1
SectorFinancial
Sector Strength70
IndustryRegulated Electric
Share Statistics
EPS (TTM)9.51
Shares Outstanding110,500,910
10 Day Avg. Volume4,513,776
30 Day Avg. Volume2,928,885
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.73
Price to Sales (P/S)0.00
P/FCF Ratio-24.59
Enterprise Value/Market Cap0.98
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-55.76K
Enterprise Value/Ebitda-16.54
Forecast
1Y Price Target
$10.00Price Target Upside65.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.2
Revenue Forecast (FY)N/A
Terra Innovatum Global Business Overview & Revenue Model
Company Description
Terra Innovatum Global N.V. is dedicated to engineering and marketing compact, modular nuclear reactor technology for various energy supply needs. These innovative reactors are specifically designed to offer standalone power, particularly suitable...
Terra Innovatum Global Earnings Call Summary
Earnings Call Date:Apr 01, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Nov 23, 2026
Earnings Call Sentiment Positive
The call presented meaningful technical and commercial progress: established regulatory engagement with the NRC, secured a qualified supply chain, validated a critical graphite reactor component with Mersen, and reported a substantial pre-commercial pipeline and sufficient cash to fund FOAK. Key risks remain around the delayed 10-K filing, the nonbinding nature of MOUs, pending NRC approvals, and the need to scale manufacturing beyond prototype pieces. On balance, the company has de-risked several execution areas and is positioned to move toward FOAK deployment, though near-term milestones and order conversion will be important to validate the opportunity.Positive Updates
Regulatory Progress and Engagement
Formal NRC licensing engagement began January 2025; ~10 topical reports and a similar number of white papers submitted to date. Management reports progressing through pre-submittal meetings (second-to-last meeting held) with construction permit phase expected to begin between June and September 2026. Company pursuing FOAK under Part 50 with planned alignment to Part 57 for accelerated commercialization.
Negative Updates
10-K Filing Delay and Procedural Nasdaq Notification
Company missed its previously communicated April 15 10-K filing target and is finalizing technical accounting for noncash items across multiple jurisdictions. Management expects to file in the near term but anticipates receiving a standard Nasdaq notification related to timing.
Read all updates
Q4-2025 Updates
Positive
Negative
Regulatory Progress and Engagement
Formal NRC licensing engagement began January 2025; ~10 topical reports and a similar number of white papers submitted to date. Management reports progressing through pre-submittal meetings (second-to-last meeting held) with construction permit phase expected to begin between June and September 2026. Company pursuing FOAK under Part 50 with planned alignment to Part 57 for accelerated commercialization.
Read all positive updates
Company Guidance
The call provided specific operational and timing guidance: Terra has roughly 200 units under non‑binding MOUs (about $4.0 billion of pre‑commercial commitments), identified 130 suppliers and narrowed those to ~30 contract partners, and has produced a Mersen graphite prototype (two blocks within tolerance after work begun Oct/Nov 2025) as it readies manufacturing; licensing formally began Jan 2025 with ~10 topical reports and a similar number of white papers submitted, monthly NRC meetings ongoing (second‑last meeting now, final pre‑construction meeting early May) and the construction‑permit phase expected to start in the June–September window; Rock City is the planned FOAK site (6 million sq ft, option for up to 50 reactors / 50 MWe, initial 15‑year term with potential up to 45 years), the company targets FOAK readiness around 2027 with broader commercialization beginning in 2028, estimates $70 million to achieve FOAK, reports >$100 million cash on hand as of 12/31/2025, and highlights product scalability (1–200 MW market, 1 MWe pilot for AI scaling to 100 MWe, and a “SOLO node” concept yielding ~20 MWe from 16 reactors) plus agreements (e.g., Ameresco and a Fortune 100 energy company) to support deployment.Terra Innovatum Global Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
14
Very Negative
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | -10.00K | 0.00 | 0.00 |
| EBITDA | -33.70M | -152.30K | -43.70K |
| Net Income | 539.50M | -33.58K | -4.47K |
Balance Sheet | |||
| Total Assets | 106.14M | 133.01K | 11.87K |
| Cash, Cash Equivalents and Short-Term Investments | 102.88M | 68.93K | 1.68K |
| Total Debt | 0.00 | 106.78K | 0.00 |
| Total Liabilities | 199.73M | 165.15K | 11.88K |
| Stockholders Equity | -93.59M | -32.14K | -4.00 |
Cash Flow | |||
| Free Cash Flow | -10.40M | -41.19K | -3.89K |
| Operating Cash Flow | -10.30M | -41.19K | -3.89K |
| Investing Cash Flow | -108.00K | -230.00M | 0.00 |
| Financing Cash Flow | 112.26M | 111.58K | 0.00 |
Terra Innovatum Global Risk Analysis
Terra Innovatum Global disclosed 68 risk factors in its most recent earnings report. Terra Innovatum Global reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Terra Innovatum Global Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
* Financial Sector Average
Performance Comparison
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.